retatrutide triple agonist glp-1 gip glucagon ly3437943 First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the Nature's Ozempic” or marketing Daily Essentials Flavor:Unflavored

retatrutide triple agonist glp-1 gip glucagon ly3437943 First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the Nature's Ozempic” or marketing Daily Essentials Flavor:Unflavored

Nature's Ozempic” or marketing myth? 🧬 Berberine is not Semaglutide. Here's what science actually says: ✓ Berberine: 2-4 kg weight loss via AMPK activation, NOT GLP-1 receptor agonism (Zhang et al., 2020

doi: 10.1016/S0140-6736(14)60976-4 110 UmpierrezGTofé PovedanoSPérez ManghiFShurzinskeLPechtnerV

Daily Essentials

Flavor:Unflavored

Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial